Intracavernosal injection therapy with and without sexological counselling in men with erectile dysfunction

BJU International

Volumn 89, Issue 9, 2002, Pages 901-904

  Van Der Windt, F ^a,b   Dohle, G R ^a   Van Der Tak, J ^a   Slob, A K ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b St Clara Hospital   (Netherlands)

Author keywords

Discontinuation; Erectile dysfunction; Impotence; Self injection; Sexological counselling

Indexed keywords

ANDROSKAT; PAPAVERINE DERIVATIVE; PAPAVERINE PLUS PHENTOLAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG WITHDRAWAL; ERECTILE DYSFUNCTION; FOLLOW UP; HEMATOMA; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT SATISFACTION; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXOLOGY; SEXUALITY; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ATTITUDE TO HEALTH; COITUS; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; INJECTIONS; MALE; MIDDLE AGED; PAPAVERINE; PATIENT SATISFACTION; PHENTOLAMINE; PROSPECTIVE STUDIES; SELF ADMINISTRATION; SEX COUNSELING;

EID: 0036090747     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2002.02777.x     Document Type: Article

References (18)

1. Intracavernosal self-injection therapy in men with erectile dysfunction. Satisfaction and attrition in 119 patients
2. The impact of marital satisfaction and psychological counselling on outcome of ICI-treatment in men with ED
3. Psychophysiological diagnostic research in males: 10 years of experience
4. Visual erotic and vibrotactile stimulation and intracavernous injection in screening men with erectile dysfunction: A 3 years experience with 406 cases
5. Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy
6. Bibliotherapy in the treatment of sexual dysfunctions: Meta-analysis
7. Intracavernosal therapy for erectile failure-impact of treatment and reasons for drop-out and dissatisfaction
8. Reasons for high drop-out rate with self-injection therapy for impotence
9. Reasons of dropout from short- and long-term self-injection therapy for impotence
10. Why do so many people drop out from auto-injection therapy for impotence?
11. Compliance to longterm vasoactive intracavernous therapy
12. Long-term follow-up of patients receiving injection therapy for erectile dysfunction
13. High attrition rate with intracavernous injection of prostaglandin E1 for impotency
14. Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction
15. Does natural erectile function improve following intracavernous injections of vasoactive drugs?
16. Reasons for discontinuing intracavernous injection therapy with prostaglandin E1 (alprostadil)
17. Predictors of success and risk factors for attrition in the use of intracavernous injection